540 related items for PubMed ID: 16574030
1. Resource utilization with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies in children with asthma.
Stempel DA, Riedel AA, Carranza Rosenzweig JR.
Curr Med Res Opin; 2006 Mar; 22(3):463-70. PubMed ID: 16574030
[Abstract] [Full Text] [Related]
2. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
Delea TE, Hagiwara M, Stanford RH, Stempel DA.
Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796
[Abstract] [Full Text] [Related]
3. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies.
Stoloff SW, Stempel DA, Meyer J, Stanford RH, Carranza Rosenzweig JR.
J Allergy Clin Immunol; 2004 Feb; 113(2):245-51. PubMed ID: 14767437
[Abstract] [Full Text] [Related]
4. Adherence to asthma controller medication regimens.
Stempel DA, Stoloff SW, Carranza Rosenzweig JR, Stanford RH, Ryskina KL, Legorreta AP.
Respir Med; 2005 Oct; 99(10):1263-7. PubMed ID: 16140227
[Abstract] [Full Text] [Related]
5. Asthma-related exacerbations, therapy switching, and therapy discontinuation: a comparison of 3 commonly used controller regimens.
O'Connor RD, Rosenzweig JR, Stanford RH, Gilmore AS, Ryskina KL, Legorreta AP, Stempel DA.
Ann Allergy Asthma Immunol; 2005 Dec; 95(6):535-40. PubMed ID: 16400892
[Abstract] [Full Text] [Related]
6. Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.
Friedman HS, Eid NS, Crespi S, Wilcox TK, Reardon G.
Clin Ther; 2009 May; 31(5):1056-63. PubMed ID: 19539106
[Abstract] [Full Text] [Related]
7. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
Friedman HS, Yawn BP.
Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
[Abstract] [Full Text] [Related]
8. Comparing outcomes in patients with persistent asthma: a registry of two therapeutic alternatives.
O'Connor RD, Gilmore AS, Manjunath R, Stanford RH, Legorreta AP, Jhingran PM.
Curr Med Res Opin; 2006 Mar; 22(3):453-61. PubMed ID: 16574029
[Abstract] [Full Text] [Related]
9. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[Abstract] [Full Text] [Related]
10. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
Blanchette CM, Culler SD, Ershoff D, Gutierrez B.
Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
[Abstract] [Full Text] [Related]
11. Low-dose fluticasone propionate with and without salmeterol in steroid-naïve patients with mild, uncontrolled asthma.
Renzi PM, Howard LA, Ortega HG, Ahmad FF, Chapman KR.
Respir Med; 2010 Apr; 104(4):510-7. PubMed ID: 19944581
[Abstract] [Full Text] [Related]
12. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
Koenig SM, Murray JJ, Wolfe J, Andersen L, Yancey S, Prillaman B, Stauffer J, Dorinsky P.
Respir Med; 2008 May; 102(5):665-73. PubMed ID: 18328683
[Abstract] [Full Text] [Related]
13. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.
Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
[Abstract] [Full Text] [Related]
14. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
Ye X, Gutierrez B, Zarotsky V, Nelson M, Blanchette CM.
Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
[Abstract] [Full Text] [Related]
15. Comparative efficacy and cost of asthma care in children with asthma treated with fluticasone propionate and montelukast.
Stempel DA, Kruzikas DT, Manjunath R.
J Pediatr; 2007 Feb; 150(2):162-7. PubMed ID: 17236894
[Abstract] [Full Text] [Related]
16. Health-care utilization and costs with fluticasone propionate and fluticasone propionate/salmeterol in asthma patients at risk for exacerbations.
Hagiwara M, Delea TE, Stanford RH.
Allergy Asthma Proc; 2014 Feb; 35(1):54-62. PubMed ID: 24433597
[Abstract] [Full Text] [Related]
17. Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily.
Kerwin EM, Nathan RA, Meltzer EO, Ortega HG, Yancey SW, Schoaf L, Dorinsky PM.
Respir Med; 2008 Apr; 102(4):495-504. PubMed ID: 18206361
[Abstract] [Full Text] [Related]
18. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[Abstract] [Full Text] [Related]
19. Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast.
Stempel DA, Mauskopf J, McLaughlin T, Yazdani C, Stanford RH.
Respir Med; 2001 Mar; 95(3):227-34. PubMed ID: 11266241
[Abstract] [Full Text] [Related]
20. Comparison of prevalence, cost, and outcomes of a combination of salmeterol and fluticasone therapy to common asthma treatments.
Wang SW, Liu X, Wiener DJ, Sennett C, Bowers BW, Legorreta AP.
Am J Manag Care; 2001 Sep; 7(9):913-22. PubMed ID: 11570024
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
